Cogentix Medical (CGNT) Tops Q2 EPS by 2c
Get Alerts CGNT Hot Sheet
Join SI Premium – FREE
Cogentix Medical (NASDAQ: CGNT) reported Q2 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $116 million versus the consensus estimate of $115.57 million.
GUIDANCE:
Cogentix Medical sees FY2021 EPS of $0.82, versus the consensus of $0.80. Cogentix Medical sees FY2021 revenue of $490 million, versus the consensus of $489 million.
For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- WM (WM) Tops Q1 EPS by 25c
- Northrim BanCorp (NRIM) Tops Q1 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!